| Drug Name |
Flecainide acetate |
| Drug ID |
BADD_D00903 |
| Description |
Flecainide is a Class I anti-arrhythmic agent like [encainide] and [propafenone].[A186880] Flecainide’s development began in 1966 and was first synthesized in 1972 as an attempt to generate new anesthetics.[A186931] It is used to prevent supraventricular and ventricular arrhythmias, as well as paroxysmal atrial fibrillation and flutter.[L8878,L5056]
Flecainide was granted FDA approval on 31 October 1985.[L8875] |
| Indications and Usage |
In New Zealand and America, flecainide is indicated to prevent supraventricular arrhythmias and ventricular arrhythmias.[L8878] In the United States, it is also indicated to prevent paroxysmal atrial fibrillation and flutter.[A186886,L5056] |
| Marketing Status |
approved; withdrawn |
| ATC Code |
C01BC04 |
| DrugBank ID |
DB01195
|
| KEGG ID |
D00638
|
| MeSH ID |
D005424
|
| PubChem ID |
41022
|
| TTD Drug ID |
D03DAP
|
| NDC Product Code |
57741-0800; 42806-817; 50268-321; 57237-064; 65862-622; 50090-5306; 62135-661; 0054-0012; 65862-621; 50090-6035; 53746-641; 57237-063; 65862-623; 65162-641; 62135-662; 63629-7982; 0054-0011; 53069-1020; 59651-123; 53746-643; 62135-660; 65162-642; 71335-1487; 71335-2172; 57741-3300; 72640-021; 50090-2968; 50268-320; 53746-642; 63629-7979; 65162-643; 65571-0001; 42806-819; 50090-5267; 57237-065; 0054-0010; 42806-818 |
| UNII |
M8U465Q1WQ
|
| Synonyms |
Flecainide | Flecainide Acetate | Flecainide Monoacetate | Flecainide Monoacetate, (R)-Isomer | Flecainide Monoacetate, (S)-Isomer | Flecainide, (R)-Isomer | Flecainide, (S)-Isomer | Flecainide, 5-HO-N-(6-oxo)-Derivative | Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer | Flecatab | R818 | Tambocor | Flecadura | Flecainide Monoacetate, (+-)-Isomer | Flecainid-Isis | Flecainid Isis | Flécaïne | Apocard |
